StockData
uniQure N.V. logo

uniQure N.V. (QURE) stock

QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.30−0.48 (-2.31%)

Close on Nov 18, 2026Market cap $1.41BP/E –Yield –

uniQure pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

uniQure's pe ratio was 3.7× on Jul 29, 2022.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jul 29, 20223.7×+0.6
2021Dec 31, 20213.1×–

More uniQure figures

See a number that looks wrong?